Evidence map›Paper›PMID 31559039›Full record

ArticleJournal of thoracic disease2019

A retrospective study analyzing missed diagnosis of lung metastases at their early stages on computed tomography.

Huai Chen, Suidan Huang, Qingsi Zeng, Min Zhang, Zhiwen Ni, Xiaoling Li, Xiaoyin Xu

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Huai ChenDepartment of Radiology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Suidan HuangDepartment of Radiology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Qingsi ZengDepartment of Radiology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Min ZhangDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Zhiwen NiDepartment of Radiology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Xiaoling LiDepartment of Radiology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Xiaoyin XuDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
First Affiliated Hospital of Guangzhou Medical University · CNGuangzhou Medical University · CNBrigham and Women's Hospital · USHarvard University · US

Funding

Computer aided diagnosis of cancer metastases in the brainR01LM012434 · NLM · BRIGHAM AND WOMEN'S HOSPITAL · PI YOUNG, GEOFFREY · 2016 to 2020
$2.9M
A novel informatics approach to understanding complex muscle fiber phenotypesR01LM011415 · NLM · BRIGHAM AND WOMEN'S HOSPITAL · PI XU, XIAOYIN · 2014 to 2017
$1.5M
Novel Informatics Techniques for Modeling and Analyzing Brain Structure for Facilitating Diagnosis of Neurological DiseasesK99LM012874 · NLM · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHANG, MIN · 2019 to 2020
$174k
NLM NIH HHS K99 LM012874NLM NIH HHS R01 LM011415NLM NIH HHS R01 LM012434
6 · The paper itself

Abstract

backgroundLungs are one of the target organs of metastases of primary lung, breast, liver, colorectal, and esophageal cancer. While computed tomography (CT) is the most widely used modality for detecting lung metastases, it is still very challenging to detect them at the earlier stages. If lung metastases could be found on CT scans at the earliest time points, patients would benefit by beginning treatment earlier. The objective of this study was to demonstrate that CT can reveal lung metastases in many cases at even earlier stages than current radiological practice may find.

methodsOne hundred patients with lung metastases were randomly selected and their surveillance CT scans were analyzed retrospectively. The patients had primary cancer in the breasts, lungs, esophagus, colorectum, and liver. All patients had multiple CT examinations of the lungs and their metastases, if any, were confirmed by subsequent CT scans. The earliest CT scans were examined to determine whether lung metastases at the same locations had been diagnosed or missed. Missed lung metastases, categorized by type of the primary cancer and adjacency to nearby blood vessels, were statistically analyzed.

resultsThere were 36/100 (36%) cases of missed lung metastases, including 15 cases of single metastasis and 21 cases of multiple metastases. There were a total of 174 missed loci of lung metastases. Where metastases were missed, there was a statistically significant difference (P<0.001) in their distribution within the sub-regions of the lungs. Adjacency to blood vessels appeared to be a significant factor in metastases being missed during diagnosis (P<0.001).

conclusionsThere was a considerable percentage of early lung metastases that were missed by radiologists but actually appeared on CT scans. The capability of CT to reveal such early metastases opens up an opportunity to move up the time points of detecting lung metastases through clinical and training improvement and technology development such as computer-aided detection.

Indexed as

Computed tomography (CT)early detectionlung metastases

Identifiers

PMID31559039
PMCPMC6753459
OpenAlexW2970911405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.